Actos Lawsuit Information
Actos Lawsuit News- 1/26/2012: Surgery can be as effective in elderly patients as in younger patients, but it does have a higher rate of postoperative complications in older individuals who have other medical problems (comorbidities). Elderly people are particularly sensitive to long-term complications, lilce the metabolic disturbances that can follow urinary diversion. In those aged 80 or older, the role of radical cystectomy is controversial. Although newer surgical techniques and improvements in care, before and after the operation, make this an option for increasing numbers of older patients, several studies suggest that its benefit is at best quite minimal, even in relatively fit octogenarians. You need to carefully weigh the benefits and risks of radical cystectomy with your multidisciplinary team before going through such an aggressive operation.
Because bladder cancer surgery can cause serious side effects and debilitation that requires significant healing time and energy, older patients usually tolerate neoadjuvant chemotherapy (given before surgery) better than adjuvant chemotherapy (given after surgery). On the other hand, because not all bladder cancer patients need chemotherapy, giving it after surgery (adjuvant therapy) offers the advantages of treating only those patients who absolutely need it. You should discuss the advantages and disadvantages of both approaches with your multidisciplinary team.
With regard to choice of chemotherapy, healthy older patients can receive the same regimens as their younger counterparts, including those that are anthracycline-based, like MVAC (see Chapter 3). However, older patients are at increased risk of developing congestive heart failure from these regimens, and gemcitabine-cisplatin is probably a better choice, especially in those with a significant cardiac risk for anthracyclines. Recent studies have shown this regimen to be just as effective as MVAC but with fewer- side effects.
More information on Actos Lawsuit:
Managing chemotherapy-associated toxicity with appropriate supportive care is crucial in the elderly population to give them the best chance of cure and survival or to provide the best palliation. Reducing tire dose of chemotherapy (or radiation therapy) based purely on chronological age may seriously affect the effectiveness of treatment. Those with metastatic disease may tolerate single-agent chemotherapy better, but tire presence of severe comorbidities, age-related frailly, or underlying severe psychosocial problems may be obstacles, even for these treatment plans. As in younger patients, trimodal therapy with bladder preservation may be an option for selected older individuals with bladder cancer (see Chapter 3). It is an aggressive treatment approach that involves radiation therapy, chemotherapy, and surgery. If an older person is too frail to undergo radical cystectomy, he or she is usually too frail to get trimodal therapy. There are a few exceptions to this general rule, and it is essential that you weigh all of the risks and benefits with your multidisciplinary care team. In frail patients, radiation therapy is sometimes used to control the symptoms of bladder cancer, but it is rarely curative.
The fatigue that usually accompanies radiation therapy can be quite profound in the elderly, even in those who are fit. Often, the logistical details (like daily travel to the hospital for a 6-week course of treatment) are the hardest for older people. It is important that you discuss these potential problems with your family and social worker before starting radiation therapy. Anemia (low red blood cell count) is common in the elderly, especially the frail elderly. It decreases the effectiveness of chemotherapy and often causes fatigue, falls, cognitive decline (for example, dementia, disorientation or confusion), and heart problems. Therefore it is essential that anemia be recognized and corrected with red blood cell transfusions or the appropriate use of erythropoiesis-stimulating agents.
Information from other sources on Actos Lawsuit:
Kidney function declines as we age. Some of the medicines that older patients take to treat both their cancer (for example, cisplatin, carboplatin, methotrexate, zoledronic acid, nonsteroidal anti-inflammatory drugs) and noncancer- related problems might make this worse. The dehydration that often accompanies cancer and its treatment can put additional stress on the kidneys. Fortunately, it is often possible to minimize these effects by carefully selecting and dosing appropriate drugs, managing “polypharmacy,” and preventing dehydration. Fatigue is a near universal complaint of older cancer patients. It is particularly a problem for those who are socially isolated or depend on others to help them with activities of daily living. It is not necessarily related to depression, but it can be. Depression is quite common in the elderly. In contrast to younger patients who often respond to a cancer diagnosis with anxiety, depression is the more common disorder in older cancer patients. With proper support and medical attention, many of these patients can safely receive anticancer treatment.
fter receiving the diagnosis of cancer, many patients report that they hear very little else their doctor tells them. Although this information will be repeated and clarified over the ensuing visits with your physician, it can also be empowering to find out more information on your own. When searching for information about any healthcare topic, you should look for two criteria. First, the information should be published by a reliable source. Articles or reviews by experts are often the highest quality resources. Second, the information should be written at an appropriate level for the reader. Very technical writing may not be appropriate for everyone, whereas some patients may want more detailed scientific information. The following resources meet these criteria, are either expert written or reviewed, and offer varying levels of scientific detail.
Our use of the term or terms Actos Lawsuit: is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Actos Lawsuit: visit our site often.
Actos Lawsuit